Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity

Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity

SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lasting for weeks after initial diagnosis. Persistent vi...

Full description

Bibliographic Details
Main Authors: Hengsheng Fang, Adam D. Wegman, Kianna Ripich, Heather Friberg, Jeffrey R. Currier, Stephen J. Thomas, Timothy P. Endy, Adam T. Waickman
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
T cells
cellular immunity
symptom duration
Online Access:https://www.mdpi.com/1999-4915/13/5/916

Internet

https://www.mdpi.com/1999-4915/13/5/916

Similar Items